134 related articles for article (PubMed ID: 2689916)
1. [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride].
Ciuffetti G; Mercuri M; Lombardini R; Palazzetti D; Rizzo MT; Parnetti L
Minerva Med; 1989 Nov; 80(11):1237-40. PubMed ID: 2689916
[TBL] [Abstract][Full Text] [Related]
2. [Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases].
Lombardini R; Ciuffetti G; Paltriccia R; Scarponi AM; Savastano V; Palazzetti D; Mercuri M; Parnetti L
Ric Clin Lab; 1989; 19 Suppl 1():117-9. PubMed ID: 2629069
[No Abstract] [Full Text] [Related]
3. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
Diamantopoulos EJ; Grigoriadou M; Ifanti G; Raptis SA
Int Angiol; 2001 Dec; 20(4):337-44. PubMed ID: 11782701
[TBL] [Abstract][Full Text] [Related]
4. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
[TBL] [Abstract][Full Text] [Related]
5. Changes in blood filterability in cerebrovascular accidents.
Boisseau MR; Freyburger G; Lorient-Roudaut MF
Wien Med Wochenschr; 1986; 136 Spec No():44-6. PubMed ID: 3825170
[TBL] [Abstract][Full Text] [Related]
6. Blood rheology changes during bezafibrate treatment.
Caimi G; Francavilla G; Romano A; Catania A; Santonocito G; Sarno A
Br J Clin Pract; 1988 Nov; 42(11):456-8. PubMed ID: 3076782
[TBL] [Abstract][Full Text] [Related]
7. [Flowmetric, thermometric and rheologic studies in obliterating arterial diseases of the lower extremities treated with buflomedil].
Dorigo B; Raspanti D; Trapani M; Albanese B; Cameli AM; Digiesi V
Minerva Med; 1985 Feb; 76(7):269-75. PubMed ID: 3974940
[TBL] [Abstract][Full Text] [Related]
8. Randomized double-blind study of flunarizine versus placebo in patients with chronic cerebrovascular disorders.
Agnoli A; Manna V; Martucci N; Fioravanti M; Ferromilone F; Cananzi A; D'Andrea G; De Rosa A; Vizioli R; Sinforiani E
Int J Clin Pharmacol Res; 1988; 8(3):189-97. PubMed ID: 3042644
[TBL] [Abstract][Full Text] [Related]
9. [Hemorrheologic disorders in obese patients. Study of the viscosity of the blood, erythrocytes, plasma, fibrinogen and the erythrocyte filtration index].
Craveri A; Tornaghi G; Paganardi L; Ranieri R; Leonardi G; Di Bella M
Minerva Med; 1987 Jul; 78(13):899-906. PubMed ID: 3601135
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of whole blood filterability with increasing age in healthy men and women.
Gelmini G; Coiro V; Ferretti P; Baroni MC; Delsignore R
Haematologica; 1989; 74(1):15-8. PubMed ID: 2498177
[TBL] [Abstract][Full Text] [Related]
11. [Hemorheologic therapy applications in coronary heart disease].
Leschke M; Motz W; Strauer BE
Wien Med Wochenschr; 1986; 136 Spec No():17-24. PubMed ID: 3825169
[TBL] [Abstract][Full Text] [Related]
12. [Erythrocyte filterability and relative viscosity in liver cirrhosis and chronic hepatitis].
Mares M; Visentin I; Radossi P; Boeri G; Girolami A
Clin Ter; 1989 May; 129(4):243-59. PubMed ID: 2527119
[TBL] [Abstract][Full Text] [Related]
13. Improvement of hemorheological abnormalities in alcoholics by an oral antioxidant.
Marotta F; Safran P; Tajiri H; Princess G; Anzulovic H; Idéo GM; Rouge A; Seal MG; Idéo G
Hepatogastroenterology; 2001; 48(38):511-7. PubMed ID: 11379344
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of frostbites. Analysis of results in twenty patients with buflomedil chlorhydrate (author's transl)].
Foray J; Baisse PE; Mont JP; Cahen C
Sem Hop; 1980 Mar 8-15; 56(9-10):490-7. PubMed ID: 6244676
[TBL] [Abstract][Full Text] [Related]
15. Hemorheological disturbances in patients with chronic cerebrovascular diseases.
Szapary L; Horvath B; Marton Z; Alexy T; Demeter N; Szots M; Klabuzai A; Kesmarky G; Juricskay I; Gaal V; Czopf J; Toth K
Clin Hemorheol Microcirc; 2004; 31(1):1-9. PubMed ID: 15272148
[TBL] [Abstract][Full Text] [Related]
16. Effect of vinpocetine on red blood cell deformability in stroke patients.
Hayakawa M
Arzneimittelforschung; 1992 Apr; 42(4):425-7. PubMed ID: 1642666
[TBL] [Abstract][Full Text] [Related]
17. Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.
Clissold SP; Lynch S; Sorkin EM
Drugs; 1987 May; 33(5):430-60. PubMed ID: 3297620
[TBL] [Abstract][Full Text] [Related]
18. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
Szapáry L; Szóts M; Horváth B; Márton Z; Alexy T; Késmárky G; Juricskay I; Nagy F; Gaál V; Pálfi A; Koltai K; Tóth K
Orv Hetil; 2003 Jun; 144(22):1085-90. PubMed ID: 12847818
[TBL] [Abstract][Full Text] [Related]
19. [Blood filterability in cerebral vascular disease].
Pretolani E; Zoli I; Battistini G; Salvi P
Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1807-11. PubMed ID: 6671039
[TBL] [Abstract][Full Text] [Related]
20. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
Ciuffetti G; Sokola E; Lombardini R; Pasqualini L; Pirro M; Mannarino E
Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
